Aldeyra Therapeutics Inc (ALDX)
R&D Expense Growth
-46.78%
Fiscal year · Period ending:
ALDX R&D Expense Growth
Latest reported-46.78%period ending
Latest reported-46.78%period ending
ALDX FY R&D Growth (YoY) (0.00% → -46.78%)
Latest values, visible window
High-resolution chart · PNG
ALDX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -46.7849% | |
| 63.703% | |
| -37.7274% | |
| 5.2731% | |
| 82.0671% | |
| -44.3513% | |
| 48.7174% | |
| 82.9295% | |
| 23.7325% | |
| 73.9636% | |
| 104.2611% | |
| 140.4669% | |
| 228.5955% | |
| -65.6212% | |
| 0% |